E-LIB Suche - Ergebnisse für: Hock, Carl E.

1

Vascular Dysfunction in Hypertension Revealed by Fourier An..:

Desiderio, Michael Carl ; Mordecai, Russell M. ; Walker, Jean.
Cardiovascular Engineering and Technology. 4 (2013) 2 - p. 209-219 , 2013

Link: https://doi.org/10.1007/..

2

Inhibition of PI3K survival pathway by LY294002 augments p5..:

Hock, Carl E. ; Xu, Baohuan ; Cavalieri, Thomas A..
The FASEB Journal. 23 (2009) S1 - p. , 2009

Link: https://doi.org/10.1096/..

3

Influence of aging on the interaction of the PI3K survival ..:

Liu, Peitan ; Xu, Baohuan ; Cavalieri, Thomas A..
The FASEB Journal. 22 (2008) S1 - p. , 2008

Link: https://doi.org/10.1096/..

4

Pifithrin‐alpha (PFT) reduces myocyte apoptosis and leukocy..:

Liu, Peitan ; Xu, Baohuan ; Cavalieri, Thomas A..
The FASEB Journal. 21 (2007) 6 - p. , 2007

Link: https://doi.org/10.1096/..

5

L-Name Enhances Microcirculatory Congestion and Cardiomyocy..:

Liu, Peitan ; Xu, Baohuan ; Forman, Lloyd J...
Shock. 17 (2002) 3 - p. 185-192 , 2002

Link: https://doi.org/10.1097/..

6

INHIBITION OF NITRIC OXIDE SYNTHESIS BY L-NAME EXACERBATES ..:

Liu, Peitan ; Xu, Baohuan ; Hock, Carl E.
Shock. 16 (2001) 3 - p. 211-217 , 2001

Link: https://doi.org/10.1097/..

7

ROLE OF INTERFERON-GAMMA IN LUNG INFLAMMATION FOLLOWING CEC..:

Yin, Kingsley ; Hock, Carl E. ; Lai, Pi-Shiang..
Shock. 12 (1999) 3 - p. 215-221 , 1999

Link: https://doi.org/10.1097/..

8

TIME-DEPENDENT CARDIOVASCULAR AND INFLAMMATORY CHANGES IN A..:

Yin, Kingsley ; Hock, Carl E. ; Tahamont, Maria.
Shock. 9 (1998) 6 - p. 434-442 , 1998

Link: https://doi.org/10.1097/..

9

Beneficial effects of combined thromboxane and leukotriene ..:

Patel, Jayesh P. ; Beck, Leslie D. ; Briglia, Frank A..
Critical Care Medicine. 23 (1995) 2 - p. 231-237 , 1995

Link: https://doi.org/10.1097/..

10

RELATIVE ROLE OF ANGIOTENSIN II AND VASOPRESSIN IN ACUTE EN..:

Edelman, Samuel B. ; Beck, Leslie D. ; Briglia, Frank A...
Critical Care Medicine. 21 (1993) 1 - p. A157 , 1993

Link: https://doi.org/10.1097/..

11

Anti-ischemic actions of a new thromboxane receptor antagon..:

Hock, Carl E. ; Brezinski, Mark E. ; Lefer, Allan M.
European Journal of Pharmacology. 122 (1986) 2 - p. 213-219 , 1986

Link: https://doi.org/10.1016/..

12

Protective action of a thromboxane synthetase inhibitor in ..:

Hock, Carl E. ; Phillips III, Gordon R. ; Lefer, Allan M.
Prostaglandins, Leukotrienes and Medicine. 17 (1985) 3 - p. 339-346 , 1985

Link: https://doi.org/10.1016/..

13

Mechanisms mediating canine renal vasoconstriction induced ..:

Hock, Carl E. ; Passmore, John C.
Life Sciences. 37 (1985) 21 - p. 1997-2003 , 1985

Link: https://doi.org/10.1016/..

14

Lack of effect of thyrotropin releasing hormone (TRH) in ci..:

Hock, Carl E. ; Lefer, Allan M.
Peptides. 6 (1985) 3 - p. 547-553 , 1985

Link: https://doi.org/10.1016/..

15

Preservation of ischemic myocardium by a new converting enz..:

Hock, Carl E ; Ribeiro, Lair G.T ; Lefer, Allan M
American Heart Journal. 109 (1985) 2 - p. 222-228 , 1985

Link: https://doi.org/10.1016/..